NCT06755827

Brief Summary

The goal of this clinical trial is to learn if an emotion regulation and self-monitoring intervention can help treat overweight and obesity in teens. The main question it aims to answer is:

  • Does emotion regulation and self-monitoring help reduce biases in teens with overweight and obesity?
  • Do changes in biases relate to changes in health functioning and health behavior? Researchers will compare the intervention to the provision of educational handouts about overweight and obesity to see if the intervention is more effective. Participants will:
  • Complete self-report questionnaires, an fMRI scan, and have their blood drawn
  • Received educational handouts or attend weekly telehealth group sessions weekly for four weeks and be asked to self-monitor their mood and behavior between sessions
  • Return to complete the same questionnaires, fMRI and blood draw procedures

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
8mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

December 17, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
1.2 years until next milestone

Study Start

First participant enrolled

February 28, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

10 months

First QC Date

December 17, 2024

Last Update Submit

February 13, 2026

Conditions

Keywords

overweightobesityadolescentsneuronal responsivenessemotion regulation

Outcome Measures

Primary Outcomes (14)

  • Percentage BOLD (Blood Oxygenation Level Dependent) signal change

    Used to index pre-post changes in neuronal responsiveness to obesity-related cues

    From enrollment to the end of treatment at week 5

  • Glucose tolerance per blood samples

    Used to index pre-post changes in health indicators linked to overweight and obesity severity

    From enrollment to the end of treatment at week 5

  • Triglycerides per blood samples

    Used to index pre-post changes in health indicators linked to overweight and obesity severity

    From enrollment to the end of treatment at week 5

  • Cholesterol per blood samples

    Used to index pre-post changes in health indicators linked to overweight and obesity severity

    From enrollment to the end of treatment at week 5

  • C peptide per blood samples

    Used to index pre-post changes in health indicators linked to overweight and obesity severity

    From enrollment to the end of treatment at week 5

  • Emotion regulation per Difficulties in Emotion Regulation Scale-Short Form (DERS-SF) and Positive Affect (DERS-PA) versions

    Used to index pre-post changes in difficulties with positive and negative emotion regulation. Sum scores and average scores for each measure and subscale are used, with higher scores indicating greater difficulties with each domain

    From enrollment to the end of treatment at week 5

  • Self-report disordered eating cognitions and behaviors per Eating Disorder Examination-Questionnaire

    Used to index pre-post changes in health behavior. Items are summed together and averaged, with higher scores indicating greater disordered eating cognitions and behaviors

    From enrollment to the end of treatment at week 5

  • Self-report average daily minutes and intensity of physical activity per Patient-Reported Outcomes Measurement Information System (PROMIS) scale

    Used to index pre-post changes in health behavior. Items are summed together with higher scores indicating greater frequency and intensity of physical activity

    From enrollment to the end of treatment at week 5

  • Self-report average daily minutes and intensity of physical activity per Physical Activity Questionnaire for Adolescents (PAQ-A)

    Used to index pre-post changes in health behavior. Items are summed together with higher scores indicating greater frequency and intensity of physical activity

    From enrollment to the end of treatment at week 5

  • Self-report average daily minutes engaging in sedentary behavior per National Health and Nutrition Examination Survey (NHANES) items

    Used to index pre-post changes in health behavior. Items are summed together with higher scores indicating more frequent sedentary behavior

    From enrollment to the end of treatment at week 5

  • Self-report acceptability per face-valid questionnaire

    Sum scored, with higher score indication higher acceptability

    From enrollment to the end of treatment at week 5

  • Percentage of sessions attended (by participant)

    Used to index intervention feasibility

    From enrollment to study completion, an average of 1 year

  • Number of participants enrolled

    Used to index intervention feasibility

    From enrollment to study completion, an average of 1 year

  • Rate of attrition

    Used to index intervention feasibility

    From enrollment to study completion, an average of 1 year

Study Arms (2)

Psychoeducation Control Group

ACTIVE COMPARATOR

Participants assigned to the psychoeducation control group will receive informational handouts about overweight and obesity, including current daily sleep, diet, and physical activity recommendations to prevent/treat overweight and obesity.

Other: Psychoeducation

Emotion Regulation and Self-Monitoring Program

EXPERIMENTAL

Participants randomized to this condition will receive an active intervention which includes 4 weeks of an emotion regulation and self-monitoring program. Participants will attend telehealth group sessions once weekly and be asked to self-monitor their mood and health behaviors daily between sessions.

Behavioral: Emotion regulation and self-monitoring to treat pediatric obesity

Interventions

Participants will attend telehealth group sessions once weekly and be asked to self-monitor their mood and health behaviors daily between sessions.

Emotion Regulation and Self-Monitoring Program

Participants who are randomized to the control group will receive an online, one-time, self-led psychoeducation program with information about current daily sleep, diet, and physical activity recommendations (e.g., information about sleep hygiene, the food pyramid, and recommendations for 60 minutes of moderate-to-vigorous physical activity daily).

Psychoeducation Control Group

Eligibility Criteria

Age11 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Being English-proficient
  • Ages 11-14
  • At or above the 85th BMI percentile based on age and sex norms
  • Having access to WIFI or cellular data to attend the telehealth groups
  • Living in a home in Lubbock County (TX) or surrounding areas.

You may not qualify if:

  • Having a psychiatric or medical diagnosis that interferes with participation (e.g., significant developmental delay; pregnancy)
  • Current enrollment in overweight/obesity treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Tech University

Lubbock, Texas, 79409, United States

RECRUITING

MeSH Terms

Conditions

OverweightObesityEmotional Regulation

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSelf-ControlSocial BehaviorBehavior

Central Study Contacts

Caroline Cummings, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 17, 2024

First Posted

January 1, 2025

Study Start

February 28, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Deidentified participant data will be shared upon request and approval. To maintain privacy/confidentiality, fMRI scans and blood samples will not be shared, though specific values can be provided upon request.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months.
Access Criteria
Access to IPD will can be requested by qualified researchers following review and approval of a research proposal, confirmation of IRB approval, and execution of a Data Sharing Agreement. For more information or to submit a request, please contact Dr. Caroline Cummings at carolicu@ttu.edu

Locations